Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03TXY
|
|||
Drug Name |
PMID28216367-compound-6d
|
|||
Synonyms |
PMID28216367-C-6d
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Middle East Respiratory Syndrome (MERS) [ICD-11: 1D64] | Preclinical | [1] | |
Severe acute respiratory syndrome (SARS) [ICD-11: 1D65] | Preclinical | [1] | ||
Therapeutic Class |
Antiviral Agents
|
|||
Structure |
Download2D MOL |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | MERS-CoV 3C-like proteinase (3CLpro) | Target Info | Inhibitor | [1] |
SARS-CoV 3C-like protease (3CLpro) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CLPro inhibitors. Antiviral Res. 2017 May;141:101-106. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.